Showing results (181-190 of 198) with videos related to
Sort By:
Pageof 20
Nature Communications|December 31, 2024
Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban populationMarie-Ming Aynaud, Lauren Caldwell, Khalid N Al-Zahrani, et al.Nature Communications|August 23, 2020
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancerQin Wu, Wail Ba-Alawi, Genevieve Deblois, et al.Nature Communications|June 5, 2020
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.Nature Communications|October 30, 2014
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progressionRajesha Rupaimoole, Sherry Y Wu, Sunila Pradeep, et al.Nature Communications|January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancerHaiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.JCI Insight|August 24, 2018
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinomaStephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumErik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.The Journal of Pathology|October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumoursJérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.Nature Genetics|September 22, 2014
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glandsIlan Weinreb, Salvatore Piscuoglio, Luciano G Martelotto, et al.Pageof 20